Filtros de búsqueda

Lista de obras de

A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLD.

artículo científico publicado en 2017

A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).

artículo científico publicado en 2008

Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimens

artículo científico publicado en 2016

Age-independent rise of inflammatory scores may contribute to accelerated aging in multi-morbidity

artículo científico publicado en 2015

Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study

artículo científico publicado en 2017

An In-Depth Analysis of Patient-Reported Outcomes in Patients With Chronic Hepatitis C Treated With Different Anti-Viral Regimens

artículo científico publicado en 2016

An exploratory study examining how nano-liquid chromatography-mass spectrometry and phosphoproteomics can differentiate patients with advanced fibrosis and higher percentage collagen in non-alcoholic fatty liver disease

Anti-adipocyte antibody response in patients with non-alcoholic fatty liver disease

artículo científico publicado en 2015

Assessment of health utilities and quality of life in patients with non-alcoholic fatty liver disease

scientific article published on 16 August 2016

Association of Serum Adipocytokines with Hepatic Steatosis and Fibrosis in Patients with Chronic Hepatitis C ⬇️

artículo científico publicado el 15 de septiembre de 2010

Association of obestatin, ghrelin, and inflammatory cytokines in obese patients with non-alcoholic fatty liver disease.

artículo científico publicado en 2011

Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008 ⬇️

artículo científico publicado el 25 de marzo de 2011

Clinical outcomes and resource utilisation in Medicare patients with chronic liver disease: a historical cohort study

artículo científico publicado en 2014

Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study

artículo científico publicado en 2010

Corrigendum to "Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study" [J Hepatol 67 (2017) 940-949].

artículo científico publicado en 2018

Corrigendum to 'Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study' [J Hepatol 67 (2017) 940-949]

scientific article published on 09 January 2020

Cytokine balance is restored as patient-reported outcomes improve in patients recovering from chronic hepatitis C

scientific article published on 03 May 2019

Development and Validation of a Primary Sclerosing Cholangitis-Specific Patient-Reported Outcomes Instrument: The PSC PRO.

artículo científico publicado en 2017

Development and validation of a hepatitis B-specific health-related quality of life instrument: CLDQ-HBV

scientific article published on 11 December 2020

Direct and Indirect Economic Burden of Chronic Liver Disease in the United States

artículo científico publicado en 2016

Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirin

artículo científico publicado en 2015

Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon-alfa and ribavirin

artículo científico publicado en 2009

Economic Burden of Hepatitis C Infection

artículo científico publicado en 2017

Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease

artículo científico publicado en 2018

Effects of Treatment of Chronic HBV Infection on Patient-reported Outcomes

artículo científico publicado en 2018

Effects of Viral Eradication With Ledipasvir and Sofosbuvir, With or Without Ribavirin, on Measures of Fatigue in Patients With Chronic Hepatitis C Virus Infection

artículo científico publicado en 2015

Epidemiology of chronic liver diseases in the USA in the past three decades

artículo científico publicado en 2019

Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden

artículo científico publicado en 2016

Factors Associated With Potential Progressive Course of Primary Biliary Cholangitis: Data From Real-world US Database

artículo científico publicado en 2019

Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient-Reported Outcomes

artículo científico publicado en 2020

French Patients with Hepatitis C Treated with Direct-Acting Antiviral Combinations: The Effect on Patient-Reported Outcomes

article

Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.

artículo científico publicado en 2009

Health utilities using SF-6D scores in Japanese patients with chronic hepatitis C treated with sofosbuvir-based regimens in clinical trials

artículo científico publicado en 2017

Health-Related Quality of Life in Adolescent Patients with Hepatitis C Genotype 1 Treated with Sofosbuvir and Ledipasvir

artículo científico publicado en 2017

Health-related quality of life in Cuban patients with chronic liver disease: a real-world experience

artículo científico publicado en 2020

Hepatic gene expression of Caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease

artículo científico publicado en 2010

Hepatic sonic hedgehog protein expression measured by computer assisted morphometry significantly correlates with features of non-alcoholic steatohepatitis

article published in 2019

Hepatitis C Patients Receiving Opioid Substitution Therapy Experience Improvement in Patient-Reported Outcomes Following Treatment with Interferon-Free Regimens.

artículo científico publicado en 2017

Hepatitis C in Patients with Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes

artículo científico publicado en 2017

Impact of healthcare reform on the payer mix among young adult emergency department utilizers across the United States (2005-2015)

article

Implementation of baby boomer hepatitis C screening and linking to care in gastroenterology practices: a multi-center pilot study

artículo científico publicado en 2016

Improvement of Hepatic Fibrosis and Patient-Reported Outcomes in Non-Alcoholic Steatohepatitis Treated with Selonsertib

artículo científico publicado en 2018

Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir

artículo científico publicado en 2015

Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease

artículo científico publicado en 2009

Interferon-Free Regimens for Chronic Hepatitis C: Barriers Due to Treatment Candidacy and Insurance Coverage

artículo científico publicado en 2015

Knowledge-based identification of soluble biomarkers: hepatic fibrosis in NAFLD as an example

artículo científico publicado en 2013

Ledipasvir/sofosbuvir regimens for chronic hepatitis C infection: Insights from a work productivity economic model from the United States

artículo científico publicado en 2015

Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016

article published in 2018

Long-Term Effects of Treatment for Chronic HBV Infection on Patient-Reported Outcomes

artículo científico publicado en 2018

Long-term Benefits of Sustained Virologic Response for Patient-Reported Outcomes in Patients With Chronic Hepatitis C Virus Infection

scientific article published on 31 July 2019

Long-term outcomes of heart transplant recipients with hepatitis C positivity: the data from the U.S. transplant registry

artículo científico publicado en 2016

Long-term outcomes of liver transplantation in patients with hepatitis C infection are not affected by HCV positivity of a donor

artículo científico publicado en 2016

Mental and Emotional Impairment in Patients With Hepatitis C is Related to Lower Work Productivity

artículo científico publicado en 2015

Modelling the Economic and Clinical Burden of Non-Alcoholic Steatohepatitis in East Asia: Data from Hong Kong

artículo científico publicado en 2020

Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD).

artículo científico publicado en 2018

Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS)

artículo científico publicado en 2010

Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates

artículo científico publicado en 2018

Nonalcoholic Steatohepatitis is the Most Rapidly Increasing Indication for Liver Transplantation in the United States

artículo científico publicado en 2020

Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease.

artículo científico publicado en 2017

Not Achieving Sustained Viral Eradication of Hepatitis C Virus After Treatment Leads to Worsening Patient-reported Outcomes

artículo científico publicado en 2020

Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients

scientific article published on 27 August 2019

Outcomes of liver transplantation by insurance types in the United States

artículo científico publicado en 2020

Outcomes trends for acute myocardial infarction, congestive heart failure, and pneumonia, 2005-2009.

artículo científico publicado en 2016

Patient-Reported Outcomes Following Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Velpatasvir, With or Without Voxilaprevir

artículo científico publicado en 2017

Patient-Reported Outcomes of Elderly Adults with Chronic Hepatitis C Treated with Interferon- and Ribavirin-Free Regimens

artículo científico publicado en 2016

Patient-reported Outcomes in Asian Patients With Chronic Hepatitis C Treated With Ledipasvir and Sofosbuvir

artículo científico publicado en 2016

Patient-reported outcomes in patients chronic viral hepatitis without cirrhosis: The impact of hepatitis B and C viral replication

artículo científico publicado en 2019

Patient-reported outcomes in patients co-infected with hepatitis C virus and human immunodeficiency virus treated with sofosbuvir and velpatasvir: The ASTRAL-5 study

artículo científico publicado en 2017

Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial

artículo científico publicado en 2016

Patients With Diabetes and Chronic Liver Disease Are at Increased Risk for Overall Mortality: A Population Study From the United States

artículo científico publicado en 2017

Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of Life

artículo científico publicado en 2019

Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study

artículo científico publicado en 2018

Performance and Validation of Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV) in Clinical Trials of Patients with Chronic Hepatitis C.

artículo científico publicado en 2016

Phosphoproteomic biomarkers predicting histologic nonalcoholic steatohepatitis and fibrosis

artículo científico publicado en 2010

Prediction of Health Utility Scores in Patients with Chronic Hepatitis C Using the Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV).

artículo científico publicado en 2017

Prevalence, mortality and healthcare utilization among Medicare beneficiaries with Hepatitis C in Haemodialysis units

scientific article published on 02 August 2019

Primary Biliary Cholangitis in Medicare Population: The Impact on Mortality and Resource Utilization

artículo científico publicado en 2019

Protein Pathway Activation Associated with Sustained Virologic Response in Patients with Chronic Hepatitis C Treated with Pegylated Interferon (PEG-IFN) and Ribavirin (RBV) ⬇️

artículo científico publicado el 4 de enero de 2011

Quality of life of Japanese patients with chronic hepatitis C treated with ledipasvir and sofosbuvir

artículo científico publicado en 2016

Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis

scientific article published on 16 February 2019

Relationships among neurotransmitters, cytokines and cognitive performance for individuals with hepatitis C achieving sustained virologic response: A pilot study

artículo científico publicado en 2019

Reply

artículo científico publicado en 2019

Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials.

artículo científico publicado en 2016

Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis

artículo científico publicado en 2015

Significant knowledge gap about non-alcoholic fatty liver disease (NAFLD) in real-world practices: a global survey of hepatologists, gastroenterologists, endocrinologists and primary care physicians

artículo científico publicado en 2020

Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes

scientific article published on 12 January 2015

Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated Cirrhosis

artículo científico publicado en 2016

Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health-related quality of life in East Asian patients with hepatitis C virus infection

scholarly article by Zobair M. Younossi published in July 2018

Sofosbuvir/velpatasvir improves patient-reported outcomes in HCV patients: Results from ASTRAL-1 placebo-controlled trial

artículo científico publicado en 2016

Superiority of Interferon-Free Regimens for Chronic Hepatitis C: The Effect on Health-Related Quality of Life and Work Productivity

artículo científico publicado en 2017

Systematic review with meta-analysis: extrahepatic manifestations in chronic hepatitis C virus-infected patients in East Asia

artículo científico publicado en 2019

The Association of Histologic and Non-invasive Tests with Adverse Clinical and Patient-Reported Outcomes in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis (NASH)

scientific article published on 08 December 2020

The Conundrum of Cryptogenic Cirrhosis: Adverse Outcomes without Treatment Options

artículo científico publicado en 2018

The Effect of Interferon-Free Regimens on Health-Related Quality of Life in East Asian Patients with Chronic Hepatitis C.

artículo científico publicado en 2017

The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe

artículo científico publicado en 2016

The impact of ledipasvir/sofosbuvir on patient-reported outcomes in cirrhotic patients with chronic hepatitis C: the SIRIUS study

artículo científico publicado en 2015

The levels of monoamine neurotransmitters and measures of mental and emotional health in HCV patients treated with ledipasvir (LDV) and sofosbuvir (SOF) with or without ribavirin (RBV).

artículo científico publicado en 2016

The outcomes of adult liver transplants in the United States from 1987 to 2013.

artículo científico publicado en 2015

The portrait of an adult liver transplant recipient in the United States from 1987 to 2013.

artículo científico publicado en 2014

Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials

artículo científico publicado en 2015

Trends in outpatient resource utilizations and outcomes for Medicare beneficiaries with nonalcoholic fatty liver disease

artículo científico publicado en 2015

Vaccination against hepatitis A and B in patients with chronic liver disease and type 2 diabetes: has anything changed?

artículo científico publicado en 2016

Validation of Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis

scientific article published on 11 January 2019

Viral eradication is required for sustained improvement of patient-reported outcomes in patients with hepatitis C

artículo científico publicado en 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda